These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11095282)

  • 1. Sirolimus vs azathioprine.
    Gleadle JM; Mason PD
    Lancet; 2000 Nov; 356(9243):1768-9. PubMed ID: 11095282
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group.
    Kahan BD
    Lancet; 2000 Jul; 356(9225):194-202. PubMed ID: 10963197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?
    Craig JC; Webster AC; McDonald SP
    Transplantation; 2009 Mar; 87(6):803-4. PubMed ID: 19300180
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
    Bhorade S; Ahya VN; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Alex CG; Bag R; Deoliveira NC; Husain A; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Garrity E
    Am J Respir Crit Care Med; 2011 Feb; 183(3):379-87. PubMed ID: 20833822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidences in immunosuppression in the maintenance of renal transplantation].
    Hernández D; González-Posada JM
    Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 8. Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations. Introduction.
    Hricik DE
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S1-2. PubMed ID: 11583937
    [No Abstract]   [Full Text] [Related]  

  • 9. Sirolimus is effective for prevention of acute rejection in primary mismatched renal allograft recipients.
    Ponticelli C
    Transplant Proc; 2001; 33(1-2):1031-2. PubMed ID: 11267177
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
    Keogh A; Richardson M; Ruygrok P; Spratt P; Galbraith A; O'Driscoll G; Macdonald P; Esmore D; Muller D; Faddy S
    Circulation; 2004 Oct; 110(17):2694-700. PubMed ID: 15262845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus: more cause for alarm?
    Agarwal PD; Lucey MR
    Liver Transpl; 2012 Sep; 18(9):1003-4. PubMed ID: 22639401
    [No Abstract]   [Full Text] [Related]  

  • 12. Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
    Smith JM; Nemeth TL; McDonald RA
    Pediatr Transplant; 2004 Oct; 8(5):445-53. PubMed ID: 15367279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus in cardiac-transplant recipients.
    Banas B; Böger C; Krämer B
    N Engl J Med; 2003 Dec; 349(23):2271-2; author reply 2271-2. PubMed ID: 14657441
    [No Abstract]   [Full Text] [Related]  

  • 14. End of the line for sirolimus in liver transplant recipients with hepatitis C virus?
    De Simone P; Saliba F; Fischer L
    Liver Transpl; 2013 Feb; 19(2):236-7. PubMed ID: 23225519
    [No Abstract]   [Full Text] [Related]  

  • 15. Sirolimus: new preparation. No tangible advance in renal transplantation.
    Prescrire Int; 2002 Dec; 11(62):165-6. PubMed ID: 12469693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for using belatacept in combination with sirolimus.
    Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
    Transplant Proc; 2010 Nov; 42(9 Suppl):S29-31. PubMed ID: 21095447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus after kidney transplantation.
    Sharif A
    BMJ; 2014 Nov; 349():g6808. PubMed ID: 25424845
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus steady-state trough concentrations are not affected by bolus methylprednisolone therapy in renal allograft recipients.
    Bäckman L; Kreis H; Morales JM; Wilczek H; Taylor R; Burke JT
    Br J Clin Pharmacol; 2002 Jul; 54(1):65-8. PubMed ID: 12100227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 20. The ups and downs of sirolimus in kidney transplantation, and the importance of reporting negative findings.
    van Gelder T
    Neth J Med; 2007 Jan; 65(1):3-4. PubMed ID: 17293633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.